- Home
- SBFM vs IMTE Comparison
SBFM vs IMTE Comparison
Compare SBFM & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- IMTE
- Stock Information
- Founded
- SBFM 2006
- IMTE 2008
- Country
- SBFM United States
- IMTE Malaysia
- Employees
- SBFM N/A
- IMTE N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- IMTE Consumer Electronics/Appliances
- Sector
- SBFM Health Care
- IMTE Consumer Staples
- Exchange
- SBFM Nasdaq
- IMTE Nasdaq
- Market Cap
- SBFM 6.5M
- IMTE 3.3M
- IPO Year
- SBFM N/A
- IMTE N/A
- Fundamental
- Price
- SBFM $1.40
- IMTE $1.00
- Analyst Decision
- SBFM Strong Buy
- IMTE
- Analyst Count
- SBFM 1
- IMTE 0
- Target Price
- SBFM $15.00
- IMTE N/A
- AVG Volume (30 Days)
- SBFM 41.6K
- IMTE 30.5K
- Earning Date
- SBFM 08-12-2025
- IMTE 10-21-2025
- Dividend Yield
- SBFM N/A
- IMTE N/A
- EPS Growth
- SBFM N/A
- IMTE N/A
- EPS
- SBFM N/A
- IMTE N/A
- Revenue
- SBFM $36,341,741.00
- IMTE $123,337.00
- Revenue This Year
- SBFM $32.20
- IMTE N/A
- Revenue Next Year
- SBFM $32.74
- IMTE N/A
- P/E Ratio
- SBFM N/A
- IMTE N/A
- Revenue Growth
- SBFM 19.22
- IMTE 4.75
- 52 Week Low
- SBFM $1.17
- IMTE $0.51
- 52 Week High
- SBFM $3.90
- IMTE $3.17
- Technical
- Relative Strength Index (RSI)
- SBFM 41.45
- IMTE 46.33
- Support Level
- SBFM $1.36
- IMTE $0.92
- Resistance Level
- SBFM $1.52
- IMTE $1.02
- Average True Range (ATR)
- SBFM 0.07
- IMTE 0.06
- MACD
- SBFM -0.00
- IMTE 0.00
- Stochastic Oscillator
- SBFM 25.00
- IMTE 45.71
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.